Unknown

Dataset Information

0

A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.


ABSTRACT: Previously we have reported that metastatic melanoma cell lines and tumor specimens have reduced expression of ADAR1 and consequently are impaired in their ability to perform A-to-I microRNA (miRNA) editing. The effects of A-to-I miRNAs editing on melanoma growth and metastasis are yet to be determined. Here we report that miR-378a-3p is undergoing A-to-I editing only in the non-metastatic but not in metastatic melanoma cells. The function of the edited form is different from its wild-type counterpart. The edited form of miR-378a-3p preferentially binds to the 3'-UTR of the PARVA oncogene and inhibits its expression, thus preventing the progression of melanoma towards the malignant phenotype. Indeed, edited miR-378a-3p but not its WT form inhibits melanoma metastasis in vivo. These results further emphasize the role of RNA editing in melanoma progression.

SUBMITTER: Velazquez-Torres G 

PROVIDER: S-EPMC5792646 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


Previously we have reported that metastatic melanoma cell lines and tumor specimens have reduced expression of ADAR1 and consequently are impaired in their ability to perform A-to-I microRNA (miRNA) editing. The effects of A-to-I miRNAs editing on melanoma growth and metastasis are yet to be determined. Here we report that miR-378a-3p is undergoing A-to-I editing only in the non-metastatic but not in metastatic melanoma cells. The function of the edited form is different from its wild-type count  ...[more]

Similar Datasets

| S-EPMC8831866 | biostudies-literature
2018-02-22 | GSE107088 | GEO
| S-EPMC7868720 | biostudies-literature
| S-EPMC7982593 | biostudies-literature
| S-EPMC7388554 | biostudies-literature
| S-EPMC7760147 | biostudies-literature
| S-EPMC7746346 | biostudies-literature
| S-EPMC5003278 | biostudies-literature
| S-EPMC9459347 | biostudies-literature
| PRJNA418978 | ENA